Symptomatic hypomagnesemia associated with gentamicin therapy.
A 57-year-old male developed hypomagnesemia, hypokalemia and hypocalcemia during the course of repeated gentamicin therapy. Renal wasting of magnesium and potassium was demonstrated. Associated endocrine abnormalities included decreased level of serum immunoreactive parathyroid hormone and increased levels of plasma renin and aldosterone. Our findings are compared to those previously reported by other investigators.
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000097:blood; D005260:Female; D005839:Gentamicins / Q000009:adverse effects*; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced; D007008:Hypokalemia / Q000139:chemically induced; D008275:Magnesium Deficiency / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000276:immunology; D012083:Renin / Q000097:blood
D005839:Gentamicins; D010281:Parathyroid Hormone; D000450:Aldosterone; D012083:Renin